U.S. Medical Equipment Stock News

NasdaqGS:DLTR
NasdaqGS:DLTRConsumer Retailing

Consumer Staples Stocks for Grocery Focused Portfolios

With grocery bills topping the worry list for 90% of Americans and almost half feeling financially vulnerable, consumer staples are back in the spotlight as households rethink every dollar. For investors, this tension between everyday stress and essential spending creates a fertile hunting ground for potential resilience plays or stocks to sidestep. This article walks through three consumer staples stocks exposed to these trends and what their stories might mean for your portfolio. The three...
NYSE:PFGC
NYSE:PFGCConsumer Retailing

Performance Food Group (PFGC) On Acquisition Led Growth And A Modest Undervalued View

Upcoming Earnings Put Performance Food Group In Focus Performance Food Group (PFGC) heads into its August 12 earnings report with expectations for higher year over year earnings on stronger revenue for the June 2026 quarter compared with the prior period. Analysts appear more cautious on those earnings prospects, with the Most Accurate Estimate sitting below the broader Zacks Consensus Estimate. This difference may influence how investors interpret any surprise in the upcoming results. See...
NasdaqCM:MBIN
NasdaqCM:MBINDiversified Financial

What Merchants Bancorp (MBIN)'s Strong Q2 2026 Earnings Surge Means For Shareholders

In the second quarter of 2026, Merchants Bancorp reported net interest income of US$136.54 million and net income of US$78.3 million, with basic and diluted earnings per share from continuing operations of US$1.48, all higher than the same period a year earlier. For the first half of 2026, the bank’s net income rose to US$146.04 million and earnings per share from continuing operations reached US$2.73, highlighting a sharp improvement in profitability compared with the prior year’s first six...
NasdaqGS:WTW
NasdaqGS:WTWInsurance

Willis Towers Watson (WTW) Could Be 6% Undervalued As SEI Partnership Draws Focus

Willis Towers Watson (WTW) stock is in focus after WTW Investments expanded its relationship with SEI Investments Company to build private markets solutions for 401(k) and other U.S. defined contribution plans. See our latest analysis for Willis Towers Watson. The expanded SEI partnership comes on the heels of a larger buyback authorization and the latest quarterly results, and the stock’s recent momentum reflects that backdrop, with a 30 day share price return of 17.52% and a 3 year total...
NYSE:KD
NYSE:KDIT

Kyndryl (KD) Stock Ignores Quarterly Loss As Margin Turnaround Beckons

Kyndryl Holdings stock barely flinched after earnings, up about 1% in midday trading around US$14, even though the headline number was a fresh quarterly loss. The market seems willing to look past a Q1 FY2027 net loss of US$55 million and a free cash flow outflow of US$401 million because the longer story is about profitability potentially turning a corner. The real hook for long term investors is not this quarter’s red ink. It is management’s effort to lift thin margins through higher value...
NasdaqGS:ASND
NasdaqGS:ASNDBiotechs

Ascendis Pharma (ASND) Could Be 20% Undervalued Following Its Recent Pullback

Ascendis Pharma (NasdaqGS:ASND) has drawn investor attention after recent trading showed the stock down about 9% over the past month, with a smaller decline over the past 3 months and relatively flat year to date. See our latest analysis for Ascendis Pharma. For Ascendis Pharma, the recent 8.9% 1 month share price decline sits on top of a softer 7 day return and leaves the year to date share price return only slightly lower overall. This hints that momentum has been fading rather than...
NYSE:LOW
NYSE:LOWSpecialty Retail

How Conflicting Analyst Signals on Earnings Expectations Could Reframe Lowe's (LOW) Risk‑Reward Profile

Lowe's recent news centers on expectations for its upcoming August 19, 2026 earnings release, where analysts now anticipate slightly lower earnings per share but higher revenue, while the stock carries a Zacks Rank of 4 (Sell) based on reduced earnings estimates. What stands out is the tension between generally favorable brokerage “Buy” ratings and a more cautious Zacks stance, which highlights how differing analyst frameworks can shape expectations for Lowe's future financial...
NYSE:FND
NYSE:FNDSpecialty Retail

Floor & Decor (FND) Is Up 12.4% After Raising 2026 Guidance and Highlighting Pro Customer Momentum

In the past week, Floor & Decor Holdings reported second-quarter 2026 results showing sales of US$1,250.27 million and net income of US$95.87 million, with diluted EPS from continuing operations of US$0.89. Management also raised full-year 2026 guidance, now expecting net sales of about US$4.77 billion to US$4.99 billion and diluted EPS of US$2.20 to US$2.45, while highlighting growing contributions from pro customers and increased share repurchases supported by strong free cash flow...
NasdaqGS:CTSH
NasdaqGS:CTSHIT

Cognizant (CTSH) Stock Still Looks Undervalued As A 35% Run Tests Fair Value

Cognizant Technology Solutions stock has climbed 34.8% over the past month, yet its broader valuation checks still lean cheap relative to its fundamentals, which raises the question of how much upside the recent move has already priced in. The 34.8% gain over the past month signals a sharp shift in sentiment, which can quickly change how much of Cognizant Technology Solutions' long term potential is already reflected in the share price. Recent AI focused partnerships and expansion efforts...
NasdaqGS:ODFL
NasdaqGS:ODFLTransportation

Is Old Dominion Freight Line (ODFL) Undervalued Following Its Second Quarter Earnings Beat?

Old Dominion Freight Line (ODFL) stock is back in focus after the company reported second quarter 2026 results with higher revenue and earnings per share, along with an update on its ongoing share repurchase program. See our latest analysis for Old Dominion Freight Line. At a share price of US$215.45, Old Dominion Freight Line has seen the share price fall 1.8% over the last day and 3.3% over the past week, while a 35.3% year to date share price return and 44.6% 1 year total shareholder...
NasdaqGS:ALNY
NasdaqGS:ALNYBiotechs

Alnylam Pharmaceuticals (ALNY) On Lowered TTR Guidance And What It Means For Valuation

Alnylam Pharmaceuticals (ALNY) is back in focus after its 28.35% intraday share price drop on July 30, 2026, following lowered 2026 TTR product sales guidance despite solid reported quarterly revenue and net income. See our latest analysis for Alnylam Pharmaceuticals. Set against this earnings release and guidance change, Alnylam Pharmaceuticals' share price has been under pressure for much of 2026, with a year to date share price return down 42.84% and a 1 year total shareholder return down...
NasdaqGS:DIOD
NasdaqGS:DIODSemiconductor

Why Diodes (DIOD) Is Up 12.5% After Strong Q2 Results And Bullish Q3 Revenue Guidance

Diodes Incorporated has reported its second-quarter 2026 results, with sales rising to US$445.53 million and net income reaching US$46.65 million, alongside guidance for third-quarter revenue of about US$510 million, plus or minus 3%. An interesting development is Diodes’ expectation for continued demand from automotive, computing, and AI infrastructure applications, building on record automotive sales and supported by the planned Elevate Semiconductor acquisition to broaden higher-margin...
NYSEAM:CMCL
NYSEAM:CMCLMetals and Mining

Caledonia Mining (CMCL) Following Blanket Exploration Results And The Case For More Upside

Caledonia Mining (NYSEAM:CMCL) is back in focus after reporting surface exploration results at the Blanket mine that point to a new near surface gold horizon and fresh processing options. See our latest analysis for Caledonia Mining. The exploration update arrived alongside a sharp rebound in Caledonia Mining’s recent trading, with the stock posting a 1 day share price return of 6.93% and a 7 day share price return of 13.68%, even though the year to date share price return is still down...
NasdaqGS:TBLA
NasdaqGS:TBLAInteractive Media and Services

Enovix Stock And 2 Financially Strong Penny Stocks Worth Watching

Energy markets remain sensitive to Middle East developments, which keeps inflation questions alive for central banks and investors. That kind of backdrop often pushes attention toward companies with stronger balance sheets, even when share prices sit below 5. The Financially Fit Penny Stocks screener filters for exactly that profile. This article highlights three stocks from the screener that could help you focus your research on penny stocks with relatively stronger financial positions. The...
NasdaqGS:FORM
NasdaqGS:FORMSemiconductor

FormFactor (FORM) On Strong Earnings And Guidance While Valuation Still Sparks Debate

FormFactor (FORM) is back in the spotlight after reporting second quarter results that were significantly higher than a year earlier, issuing upbeat third quarter guidance, and seeing analysts lift earnings estimates alongside a favorable rating. See our latest analysis for FormFactor. FormFactor's recent earnings release, guidance update, and expanded partnership with Keystone Microtech have coincided with sharp share price swings, including a 37.14% 7 day share price return and a 93.34%...
NasdaqGS:DNLI
NasdaqGS:DNLIBiotechs

Denali Therapeutics (DNLI) Stock Could Be 20% Overvalued On Cash Flow Hopes

Denali Therapeutics stock has delivered a 70.2% return over the past year, yet the current checks suggest the market price sits at a premium to its intrinsic value estimate and to what broader valuation metrics would usually flag as a bargain. The 70.2% one year gain highlights how strongly sentiment has shifted in favor of Denali Therapeutics and raises the bar for what future progress needs to justify. Expectations around the company’s ability to convert its pipeline into sustainable cash...
NYSE:PNFP
NYSE:PNFPBanks

What Pinnacle Financial Partners (PNFP)'s New Dividends and Bylaw Amendment Could Mean For Shareholders

Pinnacle Financial Partners, Inc. previously approved a series of common and preferred dividends for late summer 2026 and later adopted an amendment to its bylaws on July 29, 2026. These corporate actions, alongside management’s emphasis on loan growth and talent investment, offer fresh context for how the bank is positioning its capital structure and governance. Next, we’ll examine how the bylaw amendment and recently approved dividends might influence Pinnacle Financial Partners’ broader...
NYSE:MRK
NYSE:MRKPharmaceuticals

How Stronger 2026 Guidance And New Drug Indications At Merck (MRK) Has Changed Its Investment Story

In recent days, Merck reported Q2 2026 results with sales rising to US$16.61 billion and updated 2026 revenue guidance to US$66.3–US$67.3 billion, while also announcing regulatory momentum around KEYTRUDA’s new bladder cancer use in Canada and ENFLONSIA’s proposed expanded RSV indication in the US and EU. These developments highlight how Merck is leaning on oncology and vaccine innovations to support its earnings outlook amid acquisition-related losses and a complex late-stage...
NasdaqGS:META
NasdaqGS:METAInteractive Media and Services

How Investors May Respond To Meta Platforms (META) AI Spending Squeeze On Free Cash Flow

In late July 2026, Meta Platforms reported second-quarter results showing strong revenue of US$60.80 billion but sharply weaker free cash flow as capital spending on AI infrastructure surged, while also outlining third-quarter revenue guidance of US$61–64 billion and confirming full-year operating income is expected to exceed 2025 levels. At the same time, Meta’s decision to pour resources into AI data centers, custom silicon and products like its new Muse Spark 1.2 model and Muse Code agent...
NasdaqGS:LBTY.A
NasdaqGS:LBTY.ATelecom

Is Liberty Global (LBTY.A) Cheap Following Its Q2 2026 Earnings Update?

Liberty Global (LBTY.A) drew investor attention after reporting second quarter 2026 results that showed a much smaller net loss year on year, even as quarterly sales were slightly lower than the prior period. See our latest analysis for Liberty Global. Liberty Global’s latest results arrived after a mixed run for investors, with the share price down 13.85% over the past 90 days and the 1-year total shareholder return declining 4.17%, while the 3-year total shareholder return is positive at...
NYSE:VICI
NYSE:VICISpecialized REITs

Should VICI’s Debt-Funded Expansion and Weaker Q2 Earnings Require Action From VICI Properties (VICI) Investors?

VICI Properties Inc. recently reported second-quarter 2026 results showing revenue of US$1,058.51 million, up from US$1,001.33 million a year earlier, while net income declined to US$526.52 million from US$865.08 million and diluted EPS from continuing operations eased to US$0.48 from US$0.82. At the same time, the company’s operating and growth plans were highlighted by its pricing of US$1.75 billion in senior unsecured notes, earmarked to refinance 2026 maturities and fund broader...
NYSE:BC
NYSE:BCLeisure

Does Brunswick’s EPS Jump And Buybacks Shift The Bull Case For BC?

Brunswick Corporation recently reported past second-quarter 2026 results showing sales of US$1,557.8 million and net income of US$109.8 million, alongside the completion of a multi-year share repurchase program totaling 23,968,400 shares for US$1.66 billions since 2019. The combination of higher earnings per share and reduced share count highlights how Brunswick is using both operational performance and capital returns to reshape its financial profile. We’ll now examine how Brunswick’s...
NasdaqGS:HIMX
NasdaqGS:HIMXSemiconductor

Why Himax Technologies (HIMX) Is Up 6.5% After Strong Q2 2026 Beat And Upbeat Q3 Guidance

Himax Technologies, Inc. has reported past second-quarter 2026 results showing year-over-year increases in sales to US$227.37 million and net income to US$19.88 million, alongside higher earnings per share from continuing operations. While first-half 2026 net income and earnings per share trailed the prior year, the company’s new guidance for a 7% to 11% quarter-over-quarter revenue increase and profit of US$0.086 to US$0.103 per diluted ADS highlights management’s confidence in near-term...
NYSE:ARES
NYSE:ARESCapital Markets

Ares Management (ARES) Is Up 12.2% After Record Fundraising, Earnings And Dividends Update – Has The Bull Case Changed?

Ares Management reported past second-quarter 2026 results with revenue of US$1,428.61 million and net income of US$150.64 million, and declared quarterly dividends on its common and preferred shares payable in late September and early October 2026. The earnings release highlighted record US$36.00 billion in quarterly fundraising that lifted assets under management and fee-related earnings across credit, real estate, infrastructure, and secondaries. Against this backdrop of record fundraising...